EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma

Yue Wang, Pengxiang Wang, Hui Liu, Haokang Feng, Muzi Cao, Zefan Zhang, Keqiang Rao, Jia Fan, Xiutao Fu, Yunfan Sun

Discover Oncology · 18.08.2025 · 16 (1)

DOI: 10.1007/s12672-025-03314-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 18.08.2025. Verfasst von Yue Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shangh…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science foundation for Excellent Young Scholars of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver tumor, notable for its high heterogeneity. Glycolysis plays a critical role in tumorigenesis, progression, and drug resistance across various malignancies, while the therapeutic implications of targeting glycolysis remain underexplored. This study aims to identify glycolysis-related molecular subtypes, explore their functional heterogeneity, and develop a prognostic model for iCCA. METHODS: Consensus clustering based on 121 glycolysis-related prognostic genes was performed to classify iCCA patients. Functional enrichment analyses revealed key biological pathways associated with tumor progression. A 9-gene risk model (ALDH1B1, DDIT4, GALE, HK1, HMMR, PGAM1, PGK1, PLOD1, SAP30) was constructed using the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm and multivariate Cox regression analysis. HMMR, a glycolysis-related gene, was further investigated for its clinical significance. RESULTS: Two molecular subtypes with distinct survival outcomes (p < 0.001) were identified. Functional analyses further revealed that upregulated genes in the C1 subtype were enriched in hypoxia, TNF-α signaling via NF-κB, p53, and apoptosis pathways. A risk model effectively stratified patients into high- and low-risk groups, with worse survival in the high-risk group (p < 0.001, AUC = 0.76 for 1-year, 0.80 for 3-year). A nomogram incorporating the risk score and clinical factors (γ-GT, vascular invasion, lymph node metastasis) achieved a C-index of 0.793. Finally, we identified HMMR as a candidate prognostic biomarker for iCCA patients. Moreover, HMMR was overexpressed in iCCA and associated with poor prognosis, while its knockdown significantly reduced tumor cell proliferation, migration, and invasion (p < 0.001). CONCLUSIONS: The glycolysis-based risk model enables precise patient stratification and may facilitate clinical decision-making, while HMMR represents a promising therapeutic target, offering novel insights into iCCA prognosis and treatment.

Schlagwörter

Stichwörter der Autor:innen

GlycolysisHMMRIntrahepatic cholangiocarcinoma (iCCA)Molecular subtypesPrognostic risk modelTherapeutic target

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
  • Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, China.
  • Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. fan.jia@zs-hospital.sh.cn.
  • Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, China. fan.jia@zs-hospital.sh.cn.
  • Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. fu.xiutao@zs-hospital.sh.cn.
  • Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, China. fu.xiutao@zs-hospital.sh.cn.

Förderung

  • the National Natural Science foundation for Excellent Young Scholars of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Wang, P., Liu, H., Feng, H., Cao, M., Zhang, Z., Rao, K., Fan, J., Fu, X., & Sun, Y. (2025). Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-03314-4

Vancouver

Wang Y, Wang P, Liu H, Feng H, Cao M, Zhang Z, et al. Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma. Discover Oncology. 2025;16(1). doi:10.1007/s12672-025-03314-4

BibTeX
@article{Wang2025,
  author = {Wang, Yue and Wang, Pengxiang and Liu, Hui and Feng, Haokang and Cao, Muzi and Zhang, Zefan and Rao, Keqiang and Fan, Jia and Fu, Xiutao and Sun, Yunfan},
  title = {Identification of glycolysis-related molecular subtypes and prognostic model in intrahepatic cholangiocarcinoma},
  journal = {Discover Oncology},
  year = {2025},
  volume = {16},
  number = {1},
  doi = {10.1007/s12672-025-03314-4}
}
Kostenlos starten →